Cargando…
1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study)
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454309/ http://dx.doi.org/10.1016/j.annonc.2021.08.1594 |
| _version_ | 1784570458852556800 |
|---|---|
| author | Royo-Cebrecos, C. Ambatlle, I. Robert, Ï. Buldon, J.M. Vilanova, D. Pons, J. Serrano Baillés, E. Mahia, E. Pujadas olano, J. Cobo, F. Rodriguez, S. Albiol |
| author_facet | Royo-Cebrecos, C. Ambatlle, I. Robert, Ï. Buldon, J.M. Vilanova, D. Pons, J. Serrano Baillés, E. Mahia, E. Pujadas olano, J. Cobo, F. Rodriguez, S. Albiol |
| author_sort | Royo-Cebrecos, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454309 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543092021-09-21 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) Royo-Cebrecos, C. Ambatlle, I. Robert, Ï. Buldon, J.M. Vilanova, D. Pons, J. Serrano Baillés, E. Mahia, E. Pujadas olano, J. Cobo, F. Rodriguez, S. Albiol Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454309/ http://dx.doi.org/10.1016/j.annonc.2021.08.1594 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Royo-Cebrecos, C. Ambatlle, I. Robert, Ï. Buldon, J.M. Vilanova, D. Pons, J. Serrano Baillés, E. Mahia, E. Pujadas olano, J. Cobo, F. Rodriguez, S. Albiol 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) |
| title | 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) |
| title_full | 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) |
| title_fullStr | 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) |
| title_full_unstemmed | 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) |
| title_short | 1601P SARS-CoV-2 serological response in cancer patients in the Principality of Andorra (COVONCO study) |
| title_sort | 1601p sars-cov-2 serological response in cancer patients in the principality of andorra (covonco study) |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454309/ http://dx.doi.org/10.1016/j.annonc.2021.08.1594 |
| work_keys_str_mv | AT royocebrecosc 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT ambatllei 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT roberti 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT buldonjm 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT vilanovad 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT ponsjserrano 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT baillese 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT mahiae 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT pujadasolanoj 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT cobof 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy AT rodriguezsalbiol 1601psarscov2serologicalresponseincancerpatientsintheprincipalityofandorracovoncostudy |